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0022-2836 © 2012 Elsevier Ltd. Open accThe identiﬁcation and modelling of ligands into macromolecular models
is important for understanding molecule's function and for designing
inhibitors to modulate its activities. We describe new algorithms for the
automated building of ligands into electron density maps in crystal
structure determination. Location of the ligand-binding site is achieved by
matching numerical shape features describing the ligand to those of
density clusters using a “fragmentation-tree” density representation. The
ligand molecule is built using two distinct algorithms exploiting free
atoms with inter-atomic connectivity and Metropolis-based optimisation
of the conformational state of the ligand, producing an ensemble of
structures from which the ﬁnal model is derived. The method was
validated on several thousand entries from the Protein Data Bank. In the
majority of cases, the ligand-binding site could be correctly located and
the ligand model built with a coordinate accuracy of better than 1 Å. We
anticipate that the method will be of routine use to anyone modelling
ligands, lead compounds or even compound fragments as part of protein
functional analyses or drug design efforts.© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
The process of structure determination in macro-
molecular crystallography (MX) is considered com-
plete when all electron density in the unit cell has
been modelled to the extent possible. The identiﬁ-
cation of small compounds—ligandmolecules—and
the appreciation of their binding mode are often
keys to the understanding of chemical, biological
or pharmaceutical processes in which the examined
protein complex takes part. Highly automated
procedures for the accurate identiﬁcation of
ligand-binding sites and placement of ligands inress:
ker AXS, Östliche
ruhe, Germany.
olecular
Bank.
ess under CC BY-NC-ND licencrystallographic maps are therefore highly desir-
able, permitting the rapid, convenient and unbi-
ased completion of biological structures for
subsequent analyses.
X-ray crystallography has proven very useful for
the identiﬁcation of bound low-afﬁnity solutes
arising from the crystallisation liquor—indeed it
was one of the earliest methods capable of doing
so.1 The bound fragments located in the crystal
structure allow the location of binding sites and
directly indicate their binding modes, while their
distributions on the protein surface may help guide
the construction of new leads and drug-like mole-
cules by the association of adjacent fragments in a
“LEGO-like” manner. This formed the basis for a
crystallography-led, fragment-based approach to
drug discovery2 successfully applied to a number
of biological targets in recent years.3,4 However, a
large-scale application of this approach requires a
large effort for data collection and modelling, and
automated fragment location and building is of
obvious beneﬁt in such efforts.se.
212 Crystallographic Modelling of Bound LigandsConventionally, crystallographic ligand building
comprises a number of steps. Firstly, a suitable
binding site is identiﬁed from the electron density
and/or any other a priori available knowledge.
Subsequently, the ligand molecule is placed in that
binding site in a conformation that matches the
electron density and is stereochemically sensible in
itself as well as relative to the protein environment.
Finally, the coordinates of the ligand molecule are
reﬁned, either in real or in reciprocal space. The thus
obtained complex of the ligand with the protein is
further reﬁned against the measured diffraction
data. A search for the next bound ligand in the new
difference electron density can then be initiated. In
all cases, subsequent ﬁnal rounds of structure
reﬁnement and validation are necessary steps.
In MX, a variety of methods for automated
modelling of bound ligands have been proposed
over the last decade, each with emphasis on
different aspects of the process. All of these
approaches, in essence, ﬁt the ligand model to a
density blob, and the quality of the correspondence
is evaluated by calculating some measure of the ﬁt,
typically a local map correlation coefﬁcient. Most
methods use variations of rotational and transla-
tional placement of the target ligand model as a
whole, followed by its conformational optimisation.
The AFITT method, drawing on the power of Monte
Carlo techniques, was suggested by Wlodek et al.5
Therein, an ensemble of low-energy plausible
conformations is prepared, and each is in turn ﬁt
to the density using a force ﬁeld. The molecular
graphics application Coot6 uses an adapted form of
the X-LIGAND7 method where potential binding
sites are found using the analysis of unsatisﬁed
electron density and where a Monte Carlo method is
employed for optimisation of a ligand conformation
to best ﬁt the density blob.
A radically different approach—particularly suit-
able for the building of large ligands—was success-
fully implemented in Resolve8 and then also
provided within the Phenix suite. Therein, the
modelling is achieved via the placement of a core
fragment of the ligand with subsequent addition of
the remaining parts according to the electron
density and stereochemical considerations. An
equally novel approach—based on the modelling
of a density blob as free atoms—was implemented
in the ARP/wARP modelling suite.9,10 Atomic
assignments of the free atoms are made using a
graph-search approach leading to a full model,
which is then optimised in real space. Graph search
is also a key element of a method based on the
medial axis transform,11 where a set of points is
computed from the surface of a density blob and is
then thinned to follow the centre of the shape. The
search ligand is matched to a “thinned” subset of the
medial axis. A semiautomated procedure was
proposed12 to assist in the identiﬁcation of boundligands from unknown electron density by aligning
the surface of the binding cleft and the representa-
tive set of ligands from the Protein Data Bank
(PDB).13
A number of publications pointed to the potential
beneﬁts of using advanced mathematical features for
the automatic recognition of molecular patterns. Such
features included, for example, higher-order shape
descriptors based on spherical harmonics for super-
position of the surfaces of the ligand and the binding
cavity through minimisation of the distance between
their respective expansion coefﬁcients.14,15 More
elaborate numerical descriptors that are less limited
in their resolution of shapes, such as the Zernike
moments, allow the recording of various structural
properties in a conciseway andwere demonstrated to
be applicable to ligand description.16,17
In this paper, we describe a number of novel
techniques for shape recognition and ligand ﬁtting.
An innovative methodology for binding site identi-
ﬁcation based on the construction of a “fragmenta-
tion tree” is introduced. New shape features that aid
assignment of the appropriate site for an input
ligand are also described. The “label-swapping”
routine for ligand building previously described9,10
has been developed and combined with a new
Metropolis routine, and we demonstrate that their
combination leads to better results than with either
method alone.Results and Discussion
Implementation of the software
The developed technologies have been implemen-
ted in the ARP/wARP ligand-building module,18
providing a comprehensive and robust procedure
for accurate building of ligands into crystallographic
maps starting from separate ligand and protein
structures provided in the PDB format. The full
pipeline is shown in Fig. 1.
Pre-processing of the input information
Locating the binding site
Electron density maps are typically presented in
terms of iso-surfaces drawn/plotted at a given
contour level. These closed surfaces deﬁne contig-
uous regions of density higher than the contouring
level, which we hereafter refer to as density
clusters.
We introduce a novel method for description of a
three-dimensional electron density contoured at
different density levels, which depicts the variation
of volumes of density clusters and is extremely
useful for discriminating ligand density clusters
from background noise in a crystallographic map.
Fig. 1. Schematic representation of the three-step
procedure of crystallographic ligand building in ARP/
wARP.
213Crystallographic Modelling of Bound LigandsLet us consider a single atom whose electron
density follows an isotropic three-dimensional
normal distribution:
U rð Þ = Z
2pð Þ3= 2s3
exp −
r2
2s2
 
ð1Þ
where r is the distance from the centre of the atom,
s is the standard deviation of its density distribu-
tion and Z is a scaling factor. If this density iscontoured at a threshold ρ(r)= t, the volume inside
the contoured density cluster is:
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3
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For a given cluster, the dependence of V2/3
against ln(t)—a fragmentation tree—should be linear.
We note that an approximately linear dependence
is also observed for clusters composed of more
than one atomic Gaussian shape and computed
from resolution-truncated data. In these cases, the
scaling factor Z may be larger than the number of
electrons in the atoms.19,20 Due to overlaps of
atomic density, the observed electron density
clusters for bound ligands have somewhat smaller
volumes than would be expected from Eq. (2).
However, this does not adversely affect the use of
the fragmentation tree for recognition of the density
clusters.
When the bound ligand is fully occupied and is
pronounced in the difference density, its density
cluster has properties distinct from other clusters, as
evident in the example fragmentation tree in Fig. 2.
Upon increase of the density-contouring threshold,
the clusters of bound compounds reduce in their
volume. Ligand density areas can be recognised
from characteristic, approximately linear stretches.
The slope of a stretch reﬂects the sharpness of the
density inside the clusters—compare, for example,
the blue-coloured branch corresponding to a zinc
ion in Fig. 2 with the stretches for HEM or NRGwith
steeper slopes. The intercepts of the lines corre-
sponding to the stretches reﬂect the density height
inside the clusters. All clusters in the difference
density, which do not correspond to bound ligandsFig. 2. Fragmentation tree of the
difference electron density of the
oxyreductase structure 1ed5. The
clusters for a protoporphyrin IX
ring (HEM), N-omega-nitro-L-argi-
nine (NRG) and a zinc ion (ZN) ion
are shown in red, green and blue,
respectively. Other features in the
density map, including water mol-
ecules, are coloured black.
214 Crystallographic Modelling of Bound Ligandsbut rather to water molecules and other small
features, form the rapidly decaying “background”
region of the plot.
The density clusters for ligands eventually break
into smaller fragments upon increase of the density
threshold—see, for example, the HEM cluster in
Fig. 2. At a low level, the density for the HEM entity
is contiguous with that of several adjacent water
molecules, especially those bound to its carboxylate
groups. At ∼1.4 sigma (point 1), the contiguous iso-
surface fragments and the enclosed volume at this
stage are those of the HEM and the sulphur atom of
the cysteine residue (Cys186) that associates strong-
ly with the iron atom of HEM. At higher threshold
(approximately half-way between points 1 and 2 in
the plot), the density iso-surface remains fully intact,
and the reduction in volume of the cluster in this
range corresponds to that predicted by Eq. (2). At
point 2, the HEM cluster begins to fragment, initially
with the separation of the carboxylate groups of
HEM from the central pyrrole substructure. The
other non-core carbon atoms—CBB and CBC—
separate at point 3. The new, smaller density clusters
enclosing these fragments are represented by the
stretches of red points at lower-density volumes. At
5 sigma level (point 4), only the strong density of the
HEM iron atom and the adjacent sulphur remains.
The signiﬁcant change in volume observed here
results from the ﬁnal separation of densities associ-
ated with both atoms.
Shape matching
An electron density map calculated from the
ligand to be ﬁt is compared to each potential
density cluster based on their shapes. This is
accomplished using seven shape features that
provide a concise but thorough description of anFig. 3. Construction of the FADmolecule (PDB code 2gf3) us
its sparse density cluster and (c) one high-scored subgraph-ma
atom, which is assigned to each node. The arrow in (b) point
expansion leads to a complete model of the ligand (see also Fobject, described under Methods. The single
highest-scoring match is taken forward for further
ligand building.
Deriving ligand stereochemistry
Prior to construction of the ligand, its stereochem-
ical description is required. Such information is not
explicitly given in the input PDB ﬁle and must be
obtained from the atomic coordinates. The protocols
for stereochemical analysis are described later in the
text. Ligand building subsequently proceeds via
both label-swapping and Metropolis routines.
Building the ligand
Label swapping
The label-swapping routine was ﬁrst introduced
in 2004,9 but it is now applied in an improved
manner, with the analysis of the output also
advanced as evidenced in the following discussion.
Within the routine, a search ligand could generally
be well matched to one or more density clusters,
as occurs in the construction of FAD depicted in
Fig. 3.
We note that not all graph searches yield a com-
plete model; generally, only a few do so (Fig. 4). For
example, the assignment of the pivot atom shown
in Fig. 3a to the middle of the sparse cluster (around
the location of the phosphates of FAD) in Fig. 3b
would not lead to the complete model. The best
results were obtained following selection of up to
27 best-scored models and the use of two different
sparse representations of each density cluster. The
quality of each candidate solution is evaluated
through a scoring function that uses inter-atomic
distances, van der Waals repulsions, chiral centres
and density height at atomic positions.ing the label-swapping algorithm: (a) the search ligand, (b)
tching solution. The arrow in (a) points to the pivot ligand
s to the group of nodes (marked as balls) from which the
ig. 4).
Fig. 4. Matching of the FADmolecule (Fig. 3a) to the sparse grid shown in Fig. 3b. The evolution of the model building
process for each starting node (of 98 nodes in total) is plotted on the horizontal axis. The number of ligand atoms assigned
to a sub-cluster is on the vertical axis. The number of candidate models is delineated as follows: green stands for 0 models
in a “stack” and red indicates that only the top 100 models are kept for further expansion; grey scale colours indicate
intermediates between both extremes. Only the few labelled starting grid nodes allow for complete assignment of all
ligand atoms.
215Crystallographic Modelling of Bound LigandsThis results in up to 54 best-scored ligand-to-node
assignments; one of them is shown in Fig. 3c. The
assignments are the models of the search ligand
with distorted stereochemistry, which are tidied up
at a later stage.
Metropolis-based ligand modelling
Another 54 models are output by the Metropolis
routine, and the results are merged with those from
label swapping—thus, 108models are taken forward
for further processing. The time taken for model
building via the Metropolis algorithm depends on
the number of rotatable bonds in the ligands, with
the dependency being approximately quadratic in
our tests. A ligandwith 10 rotatable bonds should be
ﬁtted in approximately 8 s, while a ligand with 50
rotatable bonds will require approximately 100 s.
Real-space refinement
Real-space reﬁnement is applied to each of the 108
models prepared. During the reﬁnement, the density
shape of each atom is described by a spherical
Gaussian function, where its centre (xyz) and width
are optimised. In addition, the two parameters
scaling the observed electron density to the one for
the modelled ligand are reﬁned. Each of the models
is optimised to ﬁt density and the stereochemical
targets (bond distances, angle-bonded distances and
planes). The contributions from the density and the
stereochemistry residuals are dynamically weighted
to each other. Ribose rings are tested in conforma-
tions corresponding to the two puckers—the oneproviding the best ﬁt to the density is selected. Other
ring systems are currently onlymodelled in the input
conformation, and this may be addressed in the
future. In these instances, the user may input two
different models—for example, one in a “boat”
conformation and one in a “chair” conformation
for non-aromatic six-membered rings—and use the
map correlation coefﬁcient of the built models in
order to select the correct conformation.
Selection of the output ligand
Three sequences of rankings are generated from
the reﬁned models: (1) the sum of the density values
at atomic coordinates, (2) the r.m.s. shift of the
model during the reﬁnement and (3) the goodness of
ﬁt of the electron density calculated from the ﬁtted
model and the density cluster.
This goodness of ﬁt also indirectly characterises
the ﬁt to the stereochemical targets. These three
rankings are combined with weights of 0.68, 0.08
and 0.24, respectively. The highest weight corre-
sponds to the density values at ligand atomic
positions, which is the most characteristic feature
for the quality of the ﬁt. In contrast, the shift of the
model during the reﬁnement contributes little and
thus has a small weight. These weights were
obtained from training on a small test set of ligand
ensembles, with the optimisation aiming to place
those ligands built with smaller r.m.s.d. higher in
the ranking list. Normally, the best single model is
taken as the one with the best total rank. However, if
there is another model amongst the top 20 that is
sufﬁciently similar to the single best result, both are
Fig. 5. Characteristics of the ligand-building test set.
216 Crystallographic Modelling of Bound Ligandsaveraged and the “merged” model is reﬁned again.
Such ensemble averaging is repeated iteratively
until convergence.
Validation of the software
The test set
The number of unique ligands was 3462 (Fig. 5).
Ligands of sizes 5 and 6 were most abundant and
alone comprised one-third of the cases. These were
mostly phosphates and sulfates.
Approximately 20% of the ligand-building cases
concerned structures of low molecular mass (90–
200 Da), thus testing the potential of the method to
place fragment-like molecules. The majority of the
cases involved larger lead and drug-type ligands.
The largest molecule was vancomycin containing
101 non-hydrogen atoms. In only 20 cases had the
ligand more than 90 atoms. The resolution of the
data ranged from 0.75 to 5.0 Å. However, there were
only 10 cases with resolution in the range from 4.0 to
5.0 Å. In more than 50% of the cases, the ligand had aFig. 6. The overall performance
of the ligand-building procedure.
Green areas denote successful
building with an r.m.s.d. from the
PDB model of less than 1.0 Å, red
indicates building at a correctly
identiﬁed binding site but with an
r.m.s.d. higher than 1.0 Å, blue
areas correspond to ligand models
built in the wrong place, (a) 9389
cases with seven or more non-
hydrogen atoms and (b) 2773 cases
with ligand well-pronounced in the
density (real-space map correlation
of 0.8 or higher) and sizes from 20 tolocal map correlation of 80% or higher; only 33 cases
had map correlations lower than 10%.
Accuracy of the built ligands
Overall results for building the largest ligand
molecule (if more than one was present) are
presented in Fig. 6. Building the ligand that is not
the largest (e.g., attempting to build the N-omega-
nitro-L-arginine before constructing protoporphyrin
in the oxyreductase structure 1ed5) has shown only
marginally lower performance. For ligands consist-
ing of seven or more non-hydrogen atoms, the
identiﬁcation of their binding site was successful in
over 80% of the cases (Fig. 6a)—in the previously
reported method9,10 in which the binding site was
simply taken as the largest cluster in difference
density, the binding site was only found in 70% of
cases for the same type of ligand—and only when
the largest ligand was ﬁtted. The higher discrimi-
nation provided by our fragmentation tree and
shape matching approach is apparently more
accurate and rigorous than that used previously.40 atoms.
Fig. 7. Examples of ligands of
diverse sizes built in maps at
various resolutions—deposited li-
gands are shown in atom colour,
built ligands in yellow; the maps
are contoured at a level of 1.5 sigma
above the mean. (a) A sulphate ion
in bovine pancreatic ribonuclease A
built at 1.6 Å resolution with an
r.m.s.d. of 0.45 Å to the reference
structure (PDB code 1a5p); (b) the
anti-cholesterol agent atorvastatin,
bound to its biological target, HMG
coenzyme A reductase (1hwk), at
2.2 Å with an r.m.s.d. of 0.23 Å; (c) a
hexasaccharide ligand with 65 non-
hydrogen atoms bound to a bacte-
rial α-amylase (1qho) rebuilt with
an r.m.s.d. of 0.31 Å at 1.7 Å
resolution; (d) a transition-state
analogue of a plant enzyme, myr-
osinase, (1e6q) built with a coordi-
nate accuracy of 0.22 Å in a map at 1.35 Å; (e) 17-β-estradiol built with an r.m.s.d. of 0.31 Å in the map derived from a
complex with the human estrogen receptor at 3.1 Å resolution (1ere).
217Crystallographic Modelling of Bound LigandsFurthermore, the new approach should permit
ligands to be modelled into a map in any order
and not only from largest to smallest. When the
binding site was determined, accurate construction
of the ligand was possible in majority of the cases.
For ligands of a size typical of drug molecules—20
to 40 non-hydrogen atoms—that were well seen in
the density map, models with an accuracy of better
than 1.0 Å were obtained in 75% of the cases, with
the binding site being found in 96% of cases (Fig. 6b).
When using the earlier method that utilised only a
label-swapping routine, only 45% of similarly
“good” ligands could be built. The signiﬁcant
improvement achieved is a good measure of the
advantages in combining the method with a
Metropolis optimisation.Fig. 8. (a) A plant lumazine synthase inhibitor built into
a 3. 1-Å protein structure (PDB 1c41), to an r.m.s.d. of 1.9 Å
from the deposited ligand. (b) S-Adenosyl methionine
modelled in a tRNA methyltransferase enzyme (PDB
1v2x); a long ﬂexible aliphatic chain was apparently
disordered, leading to little density to guide its placement.
The variation in atom placement (the deposited model is
shown in grey, and the built model is shown in yellow)
results and explains the r.m.s.d. of 2.5 Å observed.Accurate building of the ligand entity was
possible for ligands of diverse sizes. Figure 7
illustrates that, in cases of clear difference electron
density, a small sulphur ion is built as accurately as a
larger atorvastatin molecule.
A stringent nearest-neighbour r.m.s.d. limit of
1.0 Å was not always the best measure for eval-
uating success. For example, in the built model of a
plant lumazine synthase inhibitor at 3.1 Å (Fig. 8a),
an apparently inappropriate modelling of the
inhibitor's benzene ring resulted in the incorrect
placement of the hydroxylamine group and an
apparent r.m.s.d. of 1.9 Å from the deposited
ligand. Although we classify such a model as in-
correct, we expect that it may be considered sufﬁ-
ciently accurate in many cases. Similarly, building
S-adenosyl methionine into a disordered density
leads to the observed r.m.s.d. of 2.5 Å. These two
cases exemplify the directions in which future
developments can be attempted.Conclusions
The obtained results convincingly demonstrate
the efﬁciency of the combined approaches, where
different methods complement each other. Evident-
ly, ligands can be automatically and successfully
built at various levels of crystallographic data
quality and ligand complexity. The use of both
label-swapping and Metropolis methods is superior
to using either alone as the most appropriate
algorithm can vary depending on the particular
scenario. While the label-swapping method would
218 Crystallographic Modelling of Bound Ligandsbe expected to be more sensitive to errors in phases
as it works on a per-atom basis, the Metropolis
search should compensate for this as it operates at
the level of whole rigid groups of atoms. At the same
time, the Metropolis search does not guarantee a
convergence to the global minimum, but the label-
swapping method building the model “from the
seeds” has inherently high convergence properties.
Amongst a subset of 3000 examples for which the
deposited ligand was well pronounced in density
and for which the binding site was correctly located
using the described approach, 821 were, on average,
initially built within 1.0 Å only via the Metropolis
method while 220 were accurately modelled only
via the label-swapping routine. Amongst the former
set, the average data resolution was 2.1 Å compared
to 1.8 Å for the latter, indicating the required higher
data quality for the label-swapping method as
anticipated. Since both methods ﬁnd their results
in different ways, the combined model ensemble has
a higher likelihood of containing the correct solution
compared to either method alone.
The use of the fragmentation-tree approach in
map analysis provides a very efﬁcient means for
identiﬁcation of the binding site. Due to the fact that
ligand molecules consist of bonded atoms, whose
density shapes overlap (particularly at resolutions
typical for MX structure determination), ligand
electron density has properties distinct from those
of solvent molecules and background noise. Since
noise peaks are a result of random constructive
interference of the Fourier terms, their spatial
correlation is low; hence, their cluster volumes are
high but only present at low-density levels. The
density iso-surfaces of noise shrink faster as the
contour level is increased. The fragmentation-tree-
based approach is used to identify the ligand-
binding site in cases where it is unknown or where
it can be employed for validation purposes. Indeed,
the automatic identiﬁcation of a particular ligand at
a particular location in the map may be taken as an
indication that it is more likely bound there than at
any other site.
We hope to extend our use of the fragmentation
tree in the future, as it would appear to offer much
information regarding the molecular structures
described. One example might be its use to aid the
actual identiﬁcation of ligands from a cocktail of
candidates. Most complex organic molecules with
10 or more atoms typically consist of a number of
large cores or rigid groups that are connected by
bonds around which conformational rotations may
be possible. Due to their mobility, these connections
may have lower electron density and serve as
breakpoints of the density clusters into smaller
blobs as the contour level is increased. In a
fragmentation tree, this leads to a characteristic
breakup pattern that gives hints as to the stereo-
chemistry of a ligand molecule. In cases of ligands ofunknown identity, the sizes and chemical content of
rigid groups can, to an extent, be estimated from
these breakup patterns.
Since the fragmentation tree is based on the
overlapping density between bonded atoms, it is
less powerful at very high resolutions, around 1.5 Å
or better, where individual atoms are well resolved
in the density. As a practical measure, for these
cases, the difference electron density maps were
computed from data truncated to 1.5 Å resolution.
Conversely, at a resolution of 3.0 Å or worse, density
clusters for ligands start merging with those for
unmodelled solvent and noise in the map, which
also complicates correct identiﬁcation and building
of ligand model.
The presented algorithms should be exceptionally
useful in aiding the convenient and automated
placement of ligands into density in crystallographic
research, particularly in the area of knowledge-
based drug design. In a typical real-life structure
determination exercise based on crystallographic
data, the researcher will initially build the protein
model as fully as possible. At this stage, difference
density maps can be prepared that should be of
good quality provided that the protein building has
been successful. Thus, in most cases, a ligand-
building procedure of such broad applicability as
presented should be successful in virtually all
typical structure analyses. Solvent molecules can
be modelled subsequent to the placement of the
appropriate ligands in order to complete the
structure.
There are a number of topics worthy of further
investigation. As any other ordered molecule bound
to the protein, ordered water molecules leave their
imprint in the difference density map. In the
fragmentation tree, the corresponding density
blobs appear in the lower volume regions. Indeed,
the best-ordered water molecules deﬁne a “water
horizon” below which it becomes impossible to
identify the origin of the different blobs. Remark-
ably, the “water horizon” is always present, and its
physical nature is known. Thus, it could possibly be
used as a calibrating tool to put electron density
maps on an absolute scale (electrons per cubic
angstrom), in addition to the standard deviation
(sigma) currently used. The ﬁtting of partially
ordered ligands is a real challenge even when
done manually using an experienced researcher as
a tool. It is desirable that automated procedures
could advise on which groups of a bound molecule
are giving rise to the observed density. Another
under-explored area with high potential is the use of
other shape descriptors (such as the abovemen-
tioned Zernike moments) that would be tailored to a
particular family or stereochemical group of ligand
candidates. Finally, there is a wealth of chemical
information provided by the protein environment
around the binding site. Based on our test set, we
219Crystallographic Modelling of Bound Ligandsestimate that approximately 3% of ligands in the
PDB are small fragment-type compounds that are
shape symmetric and therefore have an ambiguity
in atom placement that cannot be resolved solely
using shape. These cases may require user interven-
tion. The matching of ligands to hydrogen bond
donors/acceptors and hydrophobic pockets in the
protein, as widely used in docking approaches and
evaluated using typical scoring functions,21,22
should also aid the task of ligand modelling in
MX, especially in these speciﬁc instances.Fig. 9. Sparse representation (magenta balls and sticks)
of an electron density cluster (blue wire) for the FAD
ligand in the structure 2gf3 of sarcosine oxidase at 1.3 Å
resolution.Methods
Selection of cluster points in the fragmentation tree
We note that one does not know in advance the
contour level at which the similarity of the density
cluster at the correct location to the search ligand is
maximised. Therefore, we inspect the density at different
contour levels t ranging from 1.0 to 6.0 sigma above the
mean in steps of 0.05 sigma. All clusters at every contour
level are treated independently. The signal-to-noise ratio
is very low at this stage, typically around 0.001, that is,
for one correct ligand-binding density cluster, there are
∼1000 other clusters.
At each density threshold, we consider the 11 clusters
with the highest volume and select all branches of the
fragmentation tree in which these clusters are located
(examples of such branches are the sequences of the blue-,
green- or red-coloured points in Fig. 2). We chose to select
11 clusters as testing showed that, in this case, there is an
average 95% probability of including the correct cluster
therein; further increases in selection size did not improve
the results signiﬁcantly. The selected branches are ﬁltered
so that, at any density threshold, they lie within the
expected volume limits from N to 10N Å3 where N is the
number of non-hydrogen atoms in the search ligand. The
described branch ﬁltering provides an approximately
100-fold reduction in the number of cluster candidates.
Creating an electron density from the input ligand
The xyz coordinates of all atoms of the search ligand are
used to generate an electron density blob trimmed to the
resolution of the X-ray data. During this density genera-
tion, series terminations that result from truncation of
electron density data are modelled by convoluting the
density with a Gaussian kernel—this is equivalent to the
application of an excess B-factor that introduces a required
resolution-dependent smearing factor. A scaling factor is
also used to ensure that the integral of the density
distribution is appropriate. The electron density grid
spacing is typically 0.5 Å; cell angles are those of the
input map.
Sparse density clusters
A sparse density cluster, created as now described, is
used to model density clusters, both for calculating shapematches and for ligand building via label swapping. A
density cluster corresponding to a ligand usually contains
manymore grid points than there are atoms in that ligand.
For example, at 1.8 Å resolution, the cluster for a 15-atom
NRG molecule (Fig. 2) in the density contoured at 2.0
sigma has a volume of 58 Å3, which corresponds to 268
grid points of the map at 0.6 Å grid spacing. Rather than
processing all cluster grid points, we transform them into
a pseudo-skeleton containing a smaller number of points.
This transformation is similar to the reduction of the
problem's complexity using the free atoms' concept of
ARP/wARP18, where free atoms with no particular
chemical identity are placed into density at approximately
inter-atomic distances. To build a pseudo-skeleton, we
select a high-density pivot grid point, and we remove all
neighbouring grid points within a radius of 1.1 Å. The next
pivot is selected as the highest-density point within the
distance range 1.1–1.6 Å to the previous pivot(s). This is
iterated, resulting in a set of points that capture the spatial
distribution of the density cluster; we denote such a
representation a sparse density cluster. The number of
points in the sparse cluster is set to be always higher than
the number of ligand atoms. Since the distance range 1.1–
1.6 Å covers all bond lengths typically occurring in
ligands, such a sparse cluster can be seen as a pseudo-
molecule of interconnected atoms (Fig. 9), which can be
directly compared to the structure of the search ligand.
Automatic detection of ligand stereochemistry
A ligand connectivity tree that describes rigid groups
and overall stereochemistry is generated automatically as
follows. Pairs of atoms located at less than 2.5 Å distance
are considered as potential bonding partners. Should the
angle between two bonds involving the same atom be
smaller than 80°, the longer bond is removed from the
connectivity table. A graph search is applied to the
connectivity table to identify closed polygons (rings).
The hybridisation state of bonded atoms is inspected
using a number of criteria. Inter-atomic distances are
compared against tabulated distances for single, double
and triple bonds between the most common elements
present in carbon-containing compounds. Bonding angles
close to 109°, 120° or 180° are taken as indications of sp3,
sp2 or sp hybridisation. The local planarity is evaluated
through a least-squares plane ﬁtted to the coordinates of
an atom together with its three neighbours. If none of the
220 Crystallographic Modelling of Bound Ligandsatoms deviates from the plane by more than 0.1 Å, the
group of such connected atoms is considered locally
planar. While such checks have been shown to be
extremely robust in our tests, the input coordinates should
be sensible—otherwise, evaluation of stereochemistry
may be adversely affected.
Shape features for choosing the appropriate
binding site
The following seven shape features are used to compare
the density modelled from the input ligand to the density
clusters found using the fragmentation tree:
1. The ratio of surface points to the total number of
points in a cluster. Surface points are those with at
least one adjacent grid point having a density value
below the threshold, with grid spacing always being
set as close to 0.5 Å as possible;
2. The dimensions of the smallest rectangular box that
fully encloses the cluster;
3. The eigenvalues of the moment of inertia tensor of
the cluster about its centre of mass (computed from
density-weighted xyz coordinates; the density
values are always positive due to their thresholding
at 1.0 sigma above the mean or higher);
4. The sum of the nonoverlapping volumes of the
ligand and the cluster after their rigid-body
superposition;
5. The eigenvalues of the sample covariance matrix of
the mean-centred xyz coordinates of the points
constituting the sparse cluster; similarly eigenvalues
are computed for the search ligand model;
6. The difference vector between the two inter-
atomic distance histograms of ligand and sparse
cluster—treating all sparse cluster points as
pseudo-atoms; both histograms are binned iden-
tically in steps of 0.4 Å up to a maximum
distance of 40 Å; and
7. The same difference vector [as in (6)], calculated
using geodesic distances. The geodesic distance is
deﬁned as the sum over bonded distances between
atoms (or adjacent cluster points for a sparse density
cluster) along a connectivity path through the
molecule that links any two atoms; the shortest
such path is selected.
Features 4, 5, 6 and 7 use the ligand molecule in the
given conformation. For each feature except feature 4, the
individual scores Si are computed as follows:
Si = exp −ki 
X
j
f oð Þij − f
cð Þ
ij
 20@
1
A ð3Þ
where ki are empirical weights for each feature i, j denotes
the summation index of the dimensions of each feature
vector (1 for feature 1; 3 for features 2, 3 and 5; 200 for
features 6 and 7) and f(o) and f(c) are the feature values for
the observed and calculated clusters of the ligand density,
respectively. These seven different features are at different
scales, but each has a characteristic range of values for
correct and incorrect cluster–ligand matches: the value of
Si is between 0 and 1, approaching the latter for a perfectmatch. The individual scores Si are combined to yield the
total score for each examined cluster:
Sranking = q0 + q1S1 + N + qISI + qI + 1S21 + qI + 2S1S2
+ N + q 2 + Ið Þ!
2I! −1
S2I ð4Þ
The total score is a quadratic classiﬁer and is expressed
as a product of the weight vector q and the feature vector
S. The values of the vector q were trained using a set of
1000 protein–ligand complexes with data resolution
ranging from 1.3 to 3.1 Å and ligand sizes from 5 to 60
atoms. Only structures containing fully occupied ligands
and those having local map correlation of higher than 75%
were selected for the training set. The optimisation was
done through a random 5000-step walk in the weight
space; at each step, 20 random updates of the weight
vector were generated, and the best update was accepted
if it yielded a score (the sum of Sranking values for the 1000
training cases) higher than the one at the previous step.
Thus, the optimisation targeted a maximisation of the total
score across the range of all complexes in the training set.
Label swapping
This method was introduced by Zwart et al.,9 and only a
brief description of the most crucial aspects of the
procedure is given here. The task is to ﬁnd the subset of
a sparse cluster, a subgraph, which best matches the
ligand. This may be seen as “swapping” the identities of
the ligand atoms when they are mapped to a subgraph.
Such a procedure starts with a selection of the pivot
ligand atom (Fig. 3a), which is successively assigned to each
node of the sparse cluster (Fig. 3b). The search problem is
thus split into as many smaller subtasks as there are nodes
in the sparse cluster. From all trial models generated within
each subtask at every step, only a subset with the highest
scores need typically be kept for further extensions.
Metropolis search
A Metropolis type of optimisation is used in various
implementations of crystallographic ligand building.5–7 It
makes use of the conformational freedom of the ligand
molecule around its rotatable bonds in order to optimally
match it to the density cluster. In our implementation, the
ligand in the conformation input by the user is placed into
the density cluster to match its centre of mass and three
principal axes (one out of four possibilities), and an initial
score is calculated. This score reﬂects a density map
correlation between the ligand and the sparse cluster.
The initial model is then rotated to sample all orienta-
tions in steps of 60°, with each orientation being subject to
100 steps of Metropolis optimisation of the score. The 12
best solutions are taken to the next round and are
submitted to a further Metropolis optimisation at three
different temperatures. The initial temperature is propor-
tional to the initial score; after 4000 steps of optimisation at
this initial temperature, 5000 steps are carried out at half
the initial temperature and ﬁnally 200 steps at one-tenth of
the initial temperature. The Metropolis optimiser works
with an ensemble of randomly created initialmodels. From
this ensemble, the best 54 models are output and merged
with the result of the label-swapping algorithm.
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Model reﬁnement and map calculation were done using
REFMAC,23 FFT andMAPMASK software from the CCP4
package.24
The developed methods were evaluated on a large set of
ligand structures from the PDB using version 7.2 of the
ARP/wARP software. The diffraction data were taken
from the EDS (Electron Density Server)25 and ligand
coordinates from the heterocompound information centre
in Uppsala, HIC-Up.26 The EDS entries were ﬁltered by
the following criteria:
(a) the structure contains a protein and at least one
ligand with ﬁve or more non-hydrogen atoms;
(b) the structure does not contain DNA/RNA chains;
and
(c) at least one of the ligands in the structure must
match the HIC-Up database with the compound
name, the number of atoms and their stereochem-
ical description.
Overall, 13,985 PDB entries containing 20,568 ligands
were selected.
In order to eliminate model bias and closely mimic the
real-life situation occurring in crystal structure determi-
nation, we removed all HETATM atoms including solvent
from the PDB ﬁles and subjected the remainder to one
cycle of restrained reﬁnement with REFMAC. The
difference electron density maps were then calculated
for further analysis and ligand building.
During evaluation of software performance, a density
cluster was interpreted as having been found correctly
if it had at least one density grid point within 1 Å distance
from any of the ligand atoms from the deposited
model. After ﬁnal model building, the rebuilt ligand
models were compared to their PDB deposited struc-
tures, and the nearest-neighbour r.m.s.d. was comput-
ed. The PDB models were considered as absolutely
correct reference structures, and an r.m.s.d. to them
lower than 1.0 Å was interpreted as a successfully built
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